1
|
Physiological release of endogenous tau is stimulated by neuronal activity.
|
EMBO Rep
|
2013
|
1.57
|
2
|
Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.
|
J Biol Chem
|
2008
|
1.38
|
3
|
Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons.
|
J Cell Sci
|
2004
|
1.36
|
4
|
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
|
J Neurosci
|
2005
|
1.35
|
5
|
Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.
|
FASEB J
|
2007
|
1.24
|
6
|
A role for tau at the synapse in Alzheimer's disease pathogenesis.
|
Neuropharmacology
|
2013
|
1.21
|
7
|
Molecular motors implicated in the axonal transport of tau and alpha-synuclein.
|
J Cell Sci
|
2005
|
1.20
|
8
|
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
|
J Neurochem
|
2007
|
1.20
|
9
|
Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta.
|
J Neuropathol Exp Neurol
|
2002
|
1.16
|
10
|
Dynamic association of tau with neuronal membranes is regulated by phosphorylation.
|
Neurobiol Aging
|
2011
|
1.13
|
11
|
Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin.
|
FASEB J
|
2008
|
1.11
|
12
|
Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease.
|
FASEB J
|
2008
|
1.08
|
13
|
The importance of tau phosphorylation for neurodegenerative diseases.
|
Front Neurol
|
2013
|
1.05
|
14
|
Anti-inflammatory impact of minocycline in a mouse model of tauopathy.
|
Front Psychiatry
|
2010
|
1.03
|
15
|
Tau phosphorylation affects its axonal transport and degradation.
|
Neurobiol Aging
|
2013
|
1.00
|
16
|
Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse.
|
Neurobiol Aging
|
2011
|
0.99
|
17
|
Kinase activities increase during the development of tauopathy in htau mice.
|
J Neurochem
|
2007
|
0.98
|
18
|
Functional implications of the association of tau with the plasma membrane.
|
Biochem Soc Trans
|
2010
|
0.95
|
19
|
Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding.
|
Prion
|
2009
|
0.94
|
20
|
The microtubule-associated protein tau is also phosphorylated on tyrosine.
|
J Alzheimers Dis
|
2009
|
0.94
|
21
|
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats.
|
J Neurochem
|
2008
|
0.93
|
22
|
Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau.
|
FEBS J
|
2011
|
0.91
|
23
|
Isolation of detergent resistant microdomains from cultured neurons: detergent dependent alterations in protein composition.
|
BMC Neurosci
|
2010
|
0.89
|
24
|
The microtubule-associated protein tau is phosphorylated by Syk.
|
Biochim Biophys Acta
|
2007
|
0.86
|
25
|
NUB1 modulation of GSK3β reduces tau aggregation.
|
Hum Mol Genet
|
2012
|
0.86
|
26
|
Advances in tau-based drug discovery.
|
Expert Opin Drug Discov
|
2011
|
0.83
|
27
|
Prostate-derived sterile 20-like kinases (PSKs/TAOKs) phosphorylate tau protein and are activated in tangle-bearing neurons in Alzheimer disease.
|
J Biol Chem
|
2013
|
0.82
|
28
|
Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease.
|
Aging Cell
|
2013
|
0.79
|
29
|
Key issues in the acquisition and analysis of qualitative and quantitative mass spectrometry data for peptide-centric proteomic experiments.
|
Amino Acids
|
2012
|
0.79
|
30
|
Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β.
|
Biol Open
|
2014
|
0.77
|